We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

10 hedge funds and large institutions have $218K invested in VIVEVE MED INC in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more capital invested

Capital invested by funds: $74K → $218K (+$144K)

9% less funds holding

Funds holding: 11 → 10 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
–
Closed
3
Calls
$92K
Puts
–
Net Calls
+$92K
Net Calls Change
-$20K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$158K
2
Jane Street
Jane Street
New York
+$34.9K
3
UBS Group
UBS Group
Switzerland
+$18K
4
Two Sigma Investments
Two Sigma Investments
New York
+$16.3K
5
VFA
Valeo Financial Advisors
Indiana
+$19

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$46K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$8K
3
Victory Capital Management
Victory Capital Management
Texas
-$1K

VIVE Hedge Fund Activity: Q2 2020 in Review

10 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q2 2020, worth a combined $218K — up 195% from $74K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VIVE and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.

The largest buyer was BlackRock, adding an estimated $158K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $46K sold.

  • 10 institutional investors held VIVEVE MED INC (VIVE) as of Q2 2020, down from 11 in Q1 2020.
  • Funds reported $218K of VIVEVE MED INC stock for Q2 2020, up 195% quarter-over-quarter.
  • 2 funds opened new VIVEVE MED INC positions in Q2 2020 and 3 closed out, a net change of -1 holder.
  • The largest VIVEVE MED INC buyer in Q2 2020 was BlackRock, an estimated $158K added.
  • The largest VIVEVE MED INC seller in Q2 2020 was Renaissance Technologies, an estimated $46K sold.

Based on aggregated 13F filings for Q2 2020.